Cookie Img
Home » Products » Generic Pharmaceutical Drugs » Infliximab Injection

Infliximab Injection

Infliximab Injection
Infliximab Injection
Send Inquiry
Product Code : 68
Product Description

Infliximab Injection is used to relieve the symptoms of certain autoimmune disorders (conditions in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage) including:

How to use:

  • Rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) that is also being treated with methotrexate (Rheumatrex, Trexall)
  • Crohn's disease (condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) in adults and children 6 years of age or older that has not improved when treated with other medications
  • Ulcerative colitis (condition that causes swelling and sores in the lining of the large intestine) in adults and children 6 years of age or older that has not improved when treated with other medications
  • Ankylosing spondylitis (a condition in which the body attacks the joints of the spine and other areas causing pain and joint damage)
  • Psoriasis (a skin disease in which red, scaly patches form on some areas of the body)
  • Psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin)

Infliximab injection is in a class of medications called tumor necrosis factor-alpha (TNF-alpha) inhibitors. It works by blocking the action of TNF-alpha, a substance in the body that causes inflammation. Infliximab injection comes as a powder to be mixed with sterile water and administered intravenously (into a vein) by a doctor or nurse. It is usually given in a doctor's office once every 2 to 8 weeks, more often in the beginning of your treatment and less often as your treatment continues. It will take about 2 hours for you to receive your entire dose of infliximab injection.


3S CORPORATION
X


Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.